⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Lawdragon Spotlights DOBS Partners for Leadership in High-Stakes Trial Litigation
businesswire.com
JNJ
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy
prnewswire.com
BIIB
AMGN
LLY
JNJ
PFE
MRK
BMY
GILD
REGN
AZN
ABBV
SNY
NVO
LULU
GOOG
MSFT
AMZN
META
TSLA
NVDA
XOM
CVX
KO
PEP
MCD
DIS
BA
CAT
GS
JPM
BAC
WFC
C
T
VZ
CMCSA
NFLX
ADBE
CRM
INTC
QCOM
AMD
CSCO
HON
GE
IBM
ORCL
SAP
ACN
MU
AMAT
LRCX
ADI
TXN
NXPI
MRVL
MCHP
PYPL
CMG
SBUX
NKE
HD
PG
UNH
ELV
CVS
CI
HCA
MCK
CAH
Stem Cell Therapy Market is expected to generate a revenue of USD 404.3 Million by 2031, Globally, at 10.97% CAGR: Verified Market Research®
globenewswire.com
JNJ
GILD
Leading Mental Health Researchers and Advocates to Be Honored at Premier Suicide Prevention Gala on May 7
prnewswire.com
JNJ
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System
globenewswire.com
JNJ
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
globenewswire.com
OM
ATRC
EMBC
HSIC
BSX
JNJ
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
businesswire.com
CVRX
TAK
ICON
RANI
BAX
MDT
BDX
JNJ
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery
globenewswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MDLZ
MRK
NVS
NVO
NXPI
PFE
SNY
SWX
STM
TEI
TXN
TMO
ZBH
FMS
JBL
LMT
MDT
ON
PHI
SYK
WMT
CES 2026: El futuro está aquí USA - español USA - English India - English USA - Français USA - Deutsch Korea - 한국어 APAC - Traditional Chinese Japan - Japanese
prnewswire.com
AMD
INTC
QCOM
CAT
AMZN
META
GOOG
MSFT
RBLX
UBER
LYFT
NVDA
IBM
MU
AVGO
AMAT
MRVL
ADBE
NFLX
CHTR
SIRI
SNAP
TTD
ROKU
XPER
ABT
BIIB
BMY
GILD
JNJ
MRK
PFE
GOOGL
ORCL
CRM
CSCO
ACN
BABA
JD
SONY
DE
OSK
HPQ
DELL
Over The Counter (OTC) Drugs Market is expected to generate a revenue of USD 367.08 Billion by 2032, Globally, at 8.10% CAGR: Verified Market Research®
globenewswire.com
JNJ
BHC
GSK
NVS